Tratamiento de la hipertensión pulmonar

Abstract

In the past three decades, the treatment of choice for pulmonary hypertension has been based on three pharmacological groups targeting three distinct therapeutic targets along with a series of hygienic and dietary measures. Patients who do not respond to treatment are candidates for lung transplantation or palliative care if they are deemed ineligible for transplantation. Currently, a new drug class that acts on the activin pathway is showing highly promising results.